Seoul, Republic of Korea, 27 – 28 April 2016

Click here to access a list of training courses on tuberculosis offered by WHO Collaborating Centers and partners in the European Region.

The World Health Organization report presents the latest data and in-depth analysis for the key areas outlined in the health Sustainable Development Goals, including tuberculosis.

The World Health Organization (WHO) has evaluated a new diagnostic test - Alere DetermineTM - a urine lateral flow lipoarabinomannan assay (LF-LAM,) to determine its suitability for use in the screening or diagnosis of tuberculosis disease.

06 November 2015 - WHO has approved the use of two alternative line probe assays (LPAs), with the capability to detect TB and rifampicin resistance. This follows the 2008 recommendation by WHO on the use of LPAs for the rapid detection of rifampicin resistance. At that time, the evidence assessed was for the LPA technology, Hain Version 1 assay.

A new Global Action Framework for TB Research will foster high-quality national and global TB research needed to end the TB epidemic. A new Research for TB Elimination team, set up in the WHO Global TB Programme, will facilitate the implementation of this new framework and support the promotion of TB research both at global and country levels.

16 November 2015 ¦ GENEVA - As WHO ramps up its fight against antibiotic resistance, a new multi-country survey shows people are confused about this major threat to public health and do not understand how to prevent it from growing.

The World Health Organization (WHO) has recently released a consensus document after a meeting on the essential elements for monitoring the safety of anti-TB drugs (aDSM) in Geneva in July 2015.

The report provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care, control and research at global, regional and country levels. With 1.5 million people killed by TB in 2014, the disease ranks alongside HIV as a leading killer worldwide. 

The Checklist focuses on primary and secondary health-care facilitie and is a tool for protecting spread of TB to patients and health-care workers. The Checklist will be included in the WHO Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection.